nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—PTGER3—digestive system—acquired immunodeficiency syndrome	0.00878	0.0904	CbGeAlD
Bimatoprost—PTGER1—nervous system—acquired immunodeficiency syndrome	0.00775	0.0798	CbGeAlD
Bimatoprost—PTGER1—central nervous system—acquired immunodeficiency syndrome	0.00746	0.0768	CbGeAlD
Bimatoprost—PTGER3—lung—acquired immunodeficiency syndrome	0.00734	0.0755	CbGeAlD
Bimatoprost—PTGER3—nervous system—acquired immunodeficiency syndrome	0.00679	0.0699	CbGeAlD
Bimatoprost—PTGER3—central nervous system—acquired immunodeficiency syndrome	0.00654	0.0673	CbGeAlD
Bimatoprost—PTGFR—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00626	0.0346	CbGpPWpGaD
Bimatoprost—PTGFR—lung—acquired immunodeficiency syndrome	0.00587	0.0604	CbGeAlD
Bimatoprost—AKR1C3—blood—acquired immunodeficiency syndrome	0.00544	0.056	CbGeAlD
Bimatoprost—AKR1C3—bone marrow—acquired immunodeficiency syndrome	0.00526	0.0542	CbGeAlD
Bimatoprost—AKR1C3—spinal cord—acquired immunodeficiency syndrome	0.00524	0.0539	CbGeAlD
Bimatoprost—PTGER3—brain—acquired immunodeficiency syndrome	0.00519	0.0535	CbGeAlD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00514	0.0284	CbGpPWpGaD
Bimatoprost—AKR1C3—vagina—acquired immunodeficiency syndrome	0.00504	0.0519	CbGeAlD
Bimatoprost—PTGER3—lymph node—acquired immunodeficiency syndrome	0.00502	0.0517	CbGeAlD
Bimatoprost—AKR1C3—lung—acquired immunodeficiency syndrome	0.00477	0.0491	CbGeAlD
Bimatoprost—PTGFR—lymph node—acquired immunodeficiency syndrome	0.00401	0.0413	CbGeAlD
Bimatoprost—PTGER3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00392	0.0216	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00385	0.0213	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00377	0.0208	CbGpPWpGaD
Bimatoprost—AKR1C3—brain—acquired immunodeficiency syndrome	0.00337	0.0347	CbGeAlD
Bimatoprost—AKR1C3—lymph node—acquired immunodeficiency syndrome	0.00326	0.0336	CbGeAlD
Bimatoprost—AKR1C3—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.00319	0.0176	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00312	0.0172	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00293	0.0162	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00287	0.0158	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00282	0.0156	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00237	0.0131	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00233	0.0129	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00228	0.0126	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00225	0.0125	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00219	0.0121	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00215	0.0119	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00211	0.0116	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00206	0.0114	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00206	0.0114	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00206	0.0114	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00203	0.0112	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00201	0.0111	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00193	0.0106	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00191	0.0106	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00177	0.00981	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00174	0.00962	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00174	0.0096	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00171	0.00943	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00164	0.00905	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00164	0.00905	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00161	0.00887	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00157	0.00868	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00157	0.00866	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00152	0.0084	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.0015	0.00831	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00149	0.00822	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00147	0.00813	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00147	0.0081	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00144	0.00796	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00143	0.0079	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00141	0.0078	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00141	0.00779	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0014	0.00773	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00133	0.00733	CbGpPWpGaD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00131	0.00724	CbGpPWpGaD
Bimatoprost—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00131	0.00181	CcSEcCtD
Bimatoprost—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00131	0.00181	CcSEcCtD
Bimatoprost—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00181	CcSEcCtD
Bimatoprost—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00181	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.0013	0.0072	CbGpPWpGaD
Bimatoprost—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.00179	CcSEcCtD
Bimatoprost—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00178	CcSEcCtD
Bimatoprost—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00128	0.00177	CcSEcCtD
Bimatoprost—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.00128	0.00177	CcSEcCtD
Bimatoprost—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00177	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00127	0.00704	CbGpPWpGaD
Bimatoprost—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00127	0.00176	CcSEcCtD
Bimatoprost—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00126	0.00174	CcSEcCtD
Bimatoprost—Tension—Efavirenz—acquired immunodeficiency syndrome	0.00126	0.00174	CcSEcCtD
Bimatoprost—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00174	CcSEcCtD
Bimatoprost—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00174	CcSEcCtD
Bimatoprost—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00173	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00125	0.00689	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00125	0.00689	CbGpPWpGaD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00125	0.00688	CbGpPWpGaD
Bimatoprost—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00172	CcSEcCtD
Bimatoprost—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00172	CcSEcCtD
Bimatoprost—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.00172	CcSEcCtD
Bimatoprost—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00172	CcSEcCtD
Bimatoprost—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00124	0.00172	CcSEcCtD
Bimatoprost—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00124	0.00171	CcSEcCtD
Bimatoprost—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00124	0.00171	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.00123	0.00171	CcSEcCtD
Bimatoprost—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.00123	0.0017	CcSEcCtD
Bimatoprost—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00122	0.0017	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00122	0.00677	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00122	0.00677	CbGpPWpGaD
Bimatoprost—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00122	0.00169	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00122	0.00169	CcSEcCtD
Bimatoprost—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00122	0.00169	CcSEcCtD
Bimatoprost—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00122	0.00169	CcSEcCtD
Bimatoprost—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00122	0.00169	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00122	0.00673	CbGpPWpGaD
Bimatoprost—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00122	0.00169	CcSEcCtD
Bimatoprost—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00122	0.00168	CcSEcCtD
Bimatoprost—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.00168	CcSEcCtD
Bimatoprost—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00121	0.00168	CcSEcCtD
Bimatoprost—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00121	0.00167	CcSEcCtD
Bimatoprost—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00167	CcSEcCtD
Bimatoprost—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00167	CcSEcCtD
Bimatoprost—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.0012	0.00167	CcSEcCtD
Bimatoprost—Tension—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00167	CcSEcCtD
Bimatoprost—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.0012	0.00166	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.0012	0.00662	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.0012	0.00662	CbGpPWpGaD
Bimatoprost—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00166	CcSEcCtD
Bimatoprost—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00166	CcSEcCtD
Bimatoprost—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00165	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00119	0.00656	CbGpPWpGaD
Bimatoprost—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.00164	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Bimatoprost—Cough—Indinavir—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Bimatoprost—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Bimatoprost—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Bimatoprost—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Bimatoprost—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00117	0.00162	CcSEcCtD
Bimatoprost—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00162	CcSEcCtD
Bimatoprost—Pain—Stavudine—acquired immunodeficiency syndrome	0.00117	0.00162	CcSEcCtD
Bimatoprost—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00117	0.00162	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00116	0.00161	CcSEcCtD
Bimatoprost—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.00116	0.0016	CcSEcCtD
Bimatoprost—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.0016	CcSEcCtD
Bimatoprost—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00115	0.0016	CcSEcCtD
Bimatoprost—Pain—Abacavir—acquired immunodeficiency syndrome	0.00115	0.0016	CcSEcCtD
Bimatoprost—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00115	0.00159	CcSEcCtD
Bimatoprost—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00159	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00115	0.00159	CcSEcCtD
Bimatoprost—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00114	0.00157	CcSEcCtD
Bimatoprost—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00157	CcSEcCtD
Bimatoprost—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00113	0.00157	CcSEcCtD
Bimatoprost—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00156	CcSEcCtD
Bimatoprost—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00113	0.00156	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00112	0.0062	CbGpPWpGaD
Bimatoprost—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00155	CcSEcCtD
Bimatoprost—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00111	0.00154	CcSEcCtD
Bimatoprost—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00154	CcSEcCtD
Bimatoprost—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00153	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.0011	0.00609	CbGpPWpGaD
Bimatoprost—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.0011	0.00152	CcSEcCtD
Bimatoprost—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00152	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0011	0.00606	CbGpPWpGaD
Bimatoprost—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00151	CcSEcCtD
Bimatoprost—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00151	CcSEcCtD
Bimatoprost—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00109	0.00151	CcSEcCtD
Bimatoprost—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00109	0.00151	CcSEcCtD
Bimatoprost—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.0015	CcSEcCtD
Bimatoprost—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00108	0.0015	CcSEcCtD
Bimatoprost—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00108	0.0015	CcSEcCtD
Bimatoprost—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.0015	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.0015	CcSEcCtD
Bimatoprost—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00149	CcSEcCtD
Bimatoprost—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00108	0.00149	CcSEcCtD
Bimatoprost—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00107	0.00149	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00107	0.00593	CbGpPWpGaD
Bimatoprost—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.00148	CcSEcCtD
Bimatoprost—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00148	CcSEcCtD
Bimatoprost—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00107	0.00148	CcSEcCtD
Bimatoprost—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00147	CcSEcCtD
Bimatoprost—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00146	CcSEcCtD
Bimatoprost—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00146	CcSEcCtD
Bimatoprost—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00105	0.00145	CcSEcCtD
Bimatoprost—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00144	CcSEcCtD
Bimatoprost—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00144	CcSEcCtD
Bimatoprost—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00144	CcSEcCtD
Bimatoprost—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00103	0.00142	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00142	CcSEcCtD
Bimatoprost—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00142	CcSEcCtD
Bimatoprost—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00141	CcSEcCtD
Bimatoprost—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00102	0.00141	CcSEcCtD
Bimatoprost—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00102	0.00141	CcSEcCtD
Bimatoprost—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00141	CcSEcCtD
Bimatoprost—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00102	0.00141	CcSEcCtD
Bimatoprost—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00101	0.00141	CcSEcCtD
Bimatoprost—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0014	CcSEcCtD
Bimatoprost—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.001	0.00139	CcSEcCtD
Bimatoprost—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00139	CcSEcCtD
Bimatoprost—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.001	0.00139	CcSEcCtD
Bimatoprost—Rash—Didanosine—acquired immunodeficiency syndrome	0.000994	0.00138	CcSEcCtD
Bimatoprost—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000993	0.00138	CcSEcCtD
Bimatoprost—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000993	0.00138	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000992	0.00548	CbGpPWpGaD
Bimatoprost—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000988	0.00137	CcSEcCtD
Bimatoprost—Headache—Didanosine—acquired immunodeficiency syndrome	0.000987	0.00137	CcSEcCtD
Bimatoprost—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000986	0.00137	CcSEcCtD
Bimatoprost—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000985	0.00136	CcSEcCtD
Bimatoprost—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000983	0.00136	CcSEcCtD
Bimatoprost—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000982	0.00136	CcSEcCtD
Bimatoprost—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00098	0.00136	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000979	0.00541	CbGpPWpGaD
Bimatoprost—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000978	0.00135	CcSEcCtD
Bimatoprost—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000973	0.00135	CcSEcCtD
Bimatoprost—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000971	0.00135	CcSEcCtD
Bimatoprost—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000971	0.00134	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000971	0.00536	CbGpPWpGaD
Bimatoprost—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000968	0.00134	CcSEcCtD
Bimatoprost—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000967	0.00134	CcSEcCtD
Bimatoprost—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000964	0.00134	CcSEcCtD
Bimatoprost—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000961	0.00133	CcSEcCtD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000959	0.0053	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000958	0.00133	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000955	0.00132	CcSEcCtD
Bimatoprost—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000954	0.00132	CcSEcCtD
Bimatoprost—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000951	0.00132	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000949	0.00524	CbGpPWpGaD
Bimatoprost—Pain—Indinavir—acquired immunodeficiency syndrome	0.000946	0.00131	CcSEcCtD
Bimatoprost—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000945	0.00131	CcSEcCtD
Bimatoprost—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000943	0.00131	CcSEcCtD
Bimatoprost—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.0013	CcSEcCtD
Bimatoprost—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000936	0.0013	CcSEcCtD
Bimatoprost—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000934	0.00129	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000932	0.00515	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000932	0.00515	CbGpPWpGaD
Bimatoprost—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000932	0.00129	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000931	0.00515	CbGpPWpGaD
Bimatoprost—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000929	0.00129	CcSEcCtD
Bimatoprost—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000928	0.00129	CcSEcCtD
Bimatoprost—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000925	0.00128	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000922	0.00128	CcSEcCtD
Bimatoprost—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00092	0.00127	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000913	0.00504	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000913	0.00504	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000912	0.00504	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000911	0.00503	CbGpPWpGaD
Bimatoprost—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000908	0.00126	CcSEcCtD
Bimatoprost—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000908	0.00126	CcSEcCtD
Bimatoprost—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000907	0.00126	CcSEcCtD
Bimatoprost—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000907	0.00126	CcSEcCtD
Bimatoprost—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000905	0.00125	CcSEcCtD
Bimatoprost—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000904	0.00125	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000902	0.00125	CcSEcCtD
Bimatoprost—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000898	0.00124	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000894	0.00494	CbGpPWpGaD
Bimatoprost—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000894	0.00124	CcSEcCtD
Bimatoprost—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000893	0.00124	CcSEcCtD
Bimatoprost—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000893	0.00124	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000892	0.00493	CbGpPWpGaD
Bimatoprost—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000891	0.00123	CcSEcCtD
Bimatoprost—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000891	0.00123	CcSEcCtD
Bimatoprost—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000889	0.00123	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000888	0.00491	CbGpPWpGaD
Bimatoprost—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000888	0.00123	CcSEcCtD
Bimatoprost—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000886	0.00123	CcSEcCtD
Bimatoprost—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000884	0.00122	CcSEcCtD
Bimatoprost—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000882	0.00122	CcSEcCtD
Bimatoprost—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00088	0.00122	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000879	0.00122	CcSEcCtD
Bimatoprost—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000873	0.00121	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000869	0.0048	CbGpPWpGaD
Bimatoprost—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000866	0.0012	CcSEcCtD
Bimatoprost—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000865	0.0012	CcSEcCtD
Bimatoprost—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000864	0.0012	CcSEcCtD
Bimatoprost—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000864	0.0012	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000863	0.0012	CcSEcCtD
Bimatoprost—Rash—Stavudine—acquired immunodeficiency syndrome	0.000863	0.00119	CcSEcCtD
Bimatoprost—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000862	0.00119	CcSEcCtD
Bimatoprost—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00086	0.00119	CcSEcCtD
Bimatoprost—Headache—Stavudine—acquired immunodeficiency syndrome	0.000857	0.00119	CcSEcCtD
Bimatoprost—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000855	0.00118	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000855	0.00472	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000853	0.00472	CbGpPWpGaD
Bimatoprost—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000853	0.00118	CcSEcCtD
Bimatoprost—Rash—Abacavir—acquired immunodeficiency syndrome	0.00085	0.00118	CcSEcCtD
Bimatoprost—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000849	0.00118	CcSEcCtD
Bimatoprost—Headache—Abacavir—acquired immunodeficiency syndrome	0.000844	0.00117	CcSEcCtD
Bimatoprost—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000843	0.00117	CcSEcCtD
Bimatoprost—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000842	0.00117	CcSEcCtD
Bimatoprost—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000841	0.00117	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000839	0.00464	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000839	0.00463	CbGpPWpGaD
Bimatoprost—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000836	0.00116	CcSEcCtD
Bimatoprost—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000832	0.00115	CcSEcCtD
Bimatoprost—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000825	0.00114	CcSEcCtD
Bimatoprost—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000824	0.00114	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000824	0.00455	CbGpPWpGaD
Bimatoprost—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000822	0.00114	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000821	0.00454	CbGpPWpGaD
Bimatoprost—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000815	0.00113	CcSEcCtD
Bimatoprost—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000814	0.00113	CcSEcCtD
Bimatoprost—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000813	0.00113	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000806	0.00446	CbGpPWpGaD
Bimatoprost—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000805	0.00111	CcSEcCtD
Bimatoprost—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000801	0.00111	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000798	0.00111	CcSEcCtD
Bimatoprost—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000793	0.0011	CcSEcCtD
Bimatoprost—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000793	0.0011	CcSEcCtD
Bimatoprost—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000791	0.0011	CcSEcCtD
Bimatoprost—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000791	0.0011	CcSEcCtD
Bimatoprost—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000786	0.00109	CcSEcCtD
Bimatoprost—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000783	0.00109	CcSEcCtD
Bimatoprost—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000782	0.00108	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000768	0.00106	CcSEcCtD
Bimatoprost—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000768	0.00106	CcSEcCtD
Bimatoprost—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000761	0.00105	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00076	0.0042	CbGpPWpGaD
Bimatoprost—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000757	0.00105	CcSEcCtD
Bimatoprost—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000755	0.00105	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000753	0.00416	CbGpPWpGaD
Bimatoprost—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00075	0.00104	CcSEcCtD
Bimatoprost—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00075	0.00104	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000749	0.00414	CbGpPWpGaD
Bimatoprost—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000749	0.00104	CcSEcCtD
Bimatoprost—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000747	0.00104	CcSEcCtD
Bimatoprost—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000745	0.00103	CcSEcCtD
Bimatoprost—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000739	0.00102	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000733	0.00102	CcSEcCtD
Bimatoprost—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000731	0.00101	CcSEcCtD
Bimatoprost—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000726	0.00101	CcSEcCtD
Bimatoprost—AKR1C3—Disease—CCNT1—acquired immunodeficiency syndrome	0.000726	0.00401	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00072	0.00398	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00072	0.00398	CbGpPWpGaD
Bimatoprost—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.000994	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000709	0.00392	CbGpPWpGaD
Bimatoprost—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000707	0.00098	CcSEcCtD
Bimatoprost—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000706	0.000978	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000705	0.00389	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000705	0.00389	CbGpPWpGaD
Bimatoprost—Rash—Indinavir—acquired immunodeficiency syndrome	0.000697	0.000966	CcSEcCtD
Bimatoprost—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000697	0.000965	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000694	0.00384	CbGpPWpGaD
Bimatoprost—Headache—Indinavir—acquired immunodeficiency syndrome	0.000693	0.00096	CcSEcCtD
Bimatoprost—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000691	0.000957	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000681	0.00376	CbGpPWpGaD
Bimatoprost—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000663	0.000919	CcSEcCtD
Bimatoprost—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000661	0.000916	CcSEcCtD
Bimatoprost—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000659	0.000913	CcSEcCtD
Bimatoprost—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000658	0.000912	CcSEcCtD
Bimatoprost—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000657	0.00091	CcSEcCtD
Bimatoprost—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000655	0.000907	CcSEcCtD
Bimatoprost—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000654	0.000906	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000651	0.0036	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00064	0.00354	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00064	0.00354	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000639	0.00353	CbGpPWpGaD
Bimatoprost—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.000884	CcSEcCtD
Bimatoprost—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00063	0.000873	CcSEcCtD
Bimatoprost—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00063	0.000872	CcSEcCtD
Bimatoprost—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00063	0.000872	CcSEcCtD
Bimatoprost—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000626	0.000868	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000625	0.00346	CbGpPWpGaD
Bimatoprost—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000621	0.00086	CcSEcCtD
Bimatoprost—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000611	0.000847	CcSEcCtD
Bimatoprost—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000609	0.000844	CcSEcCtD
Bimatoprost—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000601	0.000832	CcSEcCtD
Bimatoprost—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000594	0.000823	CcSEcCtD
Bimatoprost—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000588	0.000815	CcSEcCtD
Bimatoprost—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000583	0.000807	CcSEcCtD
Bimatoprost—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000582	0.000807	CcSEcCtD
Bimatoprost—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000579	0.000802	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000563	0.00311	CbGpPWpGaD
Bimatoprost—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000561	0.000778	CcSEcCtD
Bimatoprost—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000561	0.000777	CcSEcCtD
Bimatoprost—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000561	0.000776	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00056	0.0031	CbGpPWpGaD
Bimatoprost—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000557	0.000772	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000551	0.00304	CbGpPWpGaD
Bimatoprost—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000549	0.000761	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000549	0.00303	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000538	0.00297	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000538	0.00297	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000536	0.00296	CbGpPWpGaD
Bimatoprost—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000535	0.000741	CcSEcCtD
Bimatoprost—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000535	0.000741	CcSEcCtD
Bimatoprost—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000532	0.000737	CcSEcCtD
Bimatoprost—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000529	0.000732	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000528	0.00292	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000527	0.00291	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000527	0.00291	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000527	0.00291	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000527	0.00291	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000516	0.00285	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000516	0.00285	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000509	0.00281	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000508	0.00281	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000508	0.00281	CbGpPWpGaD
Bimatoprost—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000504	0.000698	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000498	0.00275	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000487	0.00269	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000487	0.00269	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000483	0.00267	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000479	0.00265	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000478	0.00264	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000478	0.00264	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000476	0.00263	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000468	0.00259	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000468	0.00259	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00046	0.00254	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000445	0.00246	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000439	0.00242	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000402	0.00222	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000401	0.00222	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000395	0.00218	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000392	0.00217	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000386	0.00214	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000385	0.00213	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CXCR4—acquired immunodeficiency syndrome	0.000381	0.00211	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000378	0.00209	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000378	0.00209	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000377	0.00208	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000364	0.00201	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000361	0.002	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000359	0.00198	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000356	0.00197	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000353	0.00195	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000351	0.00194	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.00035	0.00193	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000332	0.00184	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000328	0.00181	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000325	0.0018	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000321	0.00177	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000314	0.00173	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000301	0.00166	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000294	0.00163	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000288	0.00159	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000284	0.00157	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000283	0.00157	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000283	0.00156	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000283	0.00156	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000279	0.00154	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000277	0.00153	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000277	0.00153	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000267	0.00148	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000267	0.00148	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CCR5—acquired immunodeficiency syndrome	0.000261	0.00144	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000259	0.00143	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000253	0.0014	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000215	0.00119	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000212	0.00117	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00021	0.00116	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000209	0.00115	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000207	0.00115	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000204	0.00113	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000203	0.00112	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.0002	0.00111	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000194	0.00107	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00019	0.00105	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000189	0.00105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000185	0.00102	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000183	0.00101	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—acquired immunodeficiency syndrome	0.000164	0.000907	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—acquired immunodeficiency syndrome	0.000156	0.000862	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00015	0.000827	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000149	0.000823	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000112	0.000619	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000111	0.000615	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.00011	0.000605	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000109	0.000602	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000106	0.000584	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—acquired immunodeficiency syndrome	8.87e-05	0.00049	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.8e-05	0.000486	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.58e-05	0.000364	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.44e-05	0.000356	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.21e-05	0.000343	CbGpPWpGaD
